Published in Transfusion on May 18, 2009
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
Biospecimen repositories: are blood donors willing to participate? Transfusion (2010) 2.33
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer (2010) 1.63
Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev (2009) 1.26
Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol (2009) 1.23
Adverse effects of plasma transfusion. Transfusion (2012) 1.23
The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev (2012) 1.14
The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev (2009) 1.06
Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion (2010) 1.04
Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion (2010) 1.01
Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion (2010) 0.98
Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury. Crit Care Clin (2012) 0.97
The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion (2013) 0.95
Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrol Dial Transplant (2013) 0.90
The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion (2010) 0.89
Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion (2011) 0.89
Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants. Blood (2013) 0.88
Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation. Br J Haematol (2014) 0.87
Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome. Transfusion (2010) 0.87
Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol (2011) 0.86
The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang (2011) 0.86
Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion. Am J Hematol (2014) 0.84
Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion (2010) 0.84
Perioperative Red Blood Cell Transfusion: Harmful or Beneficial to the Patient? Transfus Med Hemother (2012) 0.83
The how's and why's of evidence based plasma therapy. Korean J Hematol (2010) 0.82
Female donors and transfusion-related acute lung injury: A case-referent study from the International TRALI Unisex Research Group. Transfusion (2010) 0.82
Alternative blood products and clinical needs in transfusion medicine. Stem Cells Int (2012) 0.81
Transfusion-related acute lung injury after transfusion of maternal blood: a case-control study. Spine (Phila Pa 1976) (2010) 0.81
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen. Front Immunol (2016) 0.79
Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion (2013) 0.79
Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response. Transfusion (2013) 0.78
Donor screening as a TRALI risk reduction strategy. Transfusion (2009) 0.78
Experimental models of transfusion-related acute lung injury. Transfus Med Rev (2011) 0.78
Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors. Blood Transfus (2012) 0.76
Does Rh immune globulin suppress HLA sensitization in pregnancy? Transfusion (2012) 0.75
Transfusion-related acute lung injury; clinical perspectives. Korean J Anesthesiol (2015) 0.75
A Previous Miscarriage and a Previous Successful Pregnancy Have a Different Impact on HLA Antibody Formation during a Subsequent Successful Pregnancy. Front Immunol (2016) 0.75
Recent Advances in Preventing Adverse Reactions to Transfusion. F1000Res (2015) 0.75
Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion (2004) 4.48
Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med (1997) 4.44
Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med (2007) 3.69
Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion (2007) 3.38
Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion (2008) 2.87
The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol (2007) 2.45
Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev (2005) 1.91
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion (2008) 1.37
Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood (2005) 1.31
Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion (2008) 1.21
The development and persistence of leukoagglutinins in parous women. Blood (1962) 1.20
Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang (2007) 1.16
Analysis of a high-throughput HLA antibody screening assay for use with platelet donors. Transfusion (2008) 1.11
Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions. Transfus Med Rev (2007) 1.07
Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS). Transfusion (2007) 1.01
Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion (2010) 1.01
A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies. Vox Sang (2008) 0.97
A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults. Transpl Immunol (2007) 0.93
HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion (2003) 0.89
Human leukocyte antigen antibodies for monitoring transplant patients. Surg Today (2005) 0.86
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med (2004) 5.78
Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med (2012) 5.77
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science (2008) 5.76
An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med (2010) 5.32
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Global epidemiology of HTLV-I infection and associated diseases. Oncogene (2005) 4.77
Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis (2005) 4.27
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis (2012) 4.24
Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA (2002) 4.02
Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation (2013) 3.84
Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis (2002) 3.83
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology (2013) 3.35
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood (2010) 3.32
Refrigerated platelets for the treatment of acute bleeding: a review of the literature and reexamination of current standards. Shock (2014) 3.27
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann Intern Med (2014) 3.24
Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS (2002) 3.22
Correlates of beverage intake in adolescent girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (2006) 3.15
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis (2011) 3.10
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Sci Transl Med (2011) 3.08
Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med (2015) 3.03
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol (2008) 2.90
Virus and antibody dynamics in acute west nile virus infection. J Infect Dis (2008) 2.84
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis (2009) 2.82
Optimizing preoperative blood ordering with data acquired from an anesthesia information management system. Anesthesiology (2013) 2.81
Convenience, the bane of our existence, and other barriers to donating. Transfusion (2006) 2.69
Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA (2008) 2.65
Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med (2014) 2.63
Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion (2009) 2.54
Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion (2011) 2.53
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion (2005) 2.51
Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS (2010) 2.43
Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol (2010) 2.39
Blood donor satisfaction and intention of future donation. Transfusion (2008) 2.34
Biospecimen repositories: are blood donors willing to participate? Transfusion (2010) 2.33
Modeling sequence evolution in acute HIV-1 infection. J Theor Biol (2009) 2.32
The consequences of temporary deferral on future whole blood donation. Transfusion (2007) 2.31
Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Transfusion (2013) 2.30
Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg (2013) 2.29
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion (2008) 2.27
A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion (2009) 2.26
Blood donors and factors impacting the blood donation decision. Transfus Med Rev (2002) 2.25
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis (2013) 2.23
Noninfectious serious hazards of transfusion. Anesth Analg (2009) 2.21
Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr (2003) 2.21
Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol (2004) 2.21
Motivations to donate blood: demographic comparisons. Transfusion (2002) 2.20
Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest (2009) 2.18
Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis (2013) 2.17
The detection of acute HIV infection. J Infect Dis (2010) 2.14
Blood banking in China. Lancet (2002) 2.10
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog (2013) 2.06
Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg (2014) 2.04
Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion (2009) 2.04
The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion (2005) 2.02
Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion (2009) 2.00
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion (2003) 2.00
Kinetics of early T cell receptor signaling regulate the pathway of lytic granule delivery to the secretory domain. Immunity (2009) 1.98
Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion (2008) 1.95
The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS (2011) 1.94
Obesity development during adolescence in a biracial cohort: the NHLBI Growth and Health Study. Pediatrics (2002) 1.92
A randomized trial of blood donor recruitment strategies. Transfusion (2006) 1.89
The whole is greater than the sum of its parts: hemostatic profiles of whole blood variants. J Trauma Acute Care Surg (2014) 1.88
Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion (2010) 1.88
The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med (2005) 1.88
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7. PLoS Pathog (2012) 1.88
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood (2008) 1.88
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis (2012) 1.86
Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men. Transfusion (2009) 1.85
Donation archives and prospective donor-recipient repositories: indispensable tools for monitoring blood safety. Transfusion (2007) 1.85
Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil. Transfusion (2005) 1.84
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses (2006) 1.83